Cancer-associated fibroblasts gene signature: a novel approach to survival prediction and immunotherapy guidance in colon cancer
Our CAFG signature provides important insights into the role of CAF cells in influencing COAD prognosis. It may also serve as a guide for selecting immunotherapy options and predicting chemotherapy responses in COAD patients.
Authors
- Chi Yang (ORCID: https://orcid.org/0000-0003-1630-5389)
- Shuangjiu Hu
- Zhaohui Wang (ORCID: https://orcid.org/0000-0001-5786-5660)
- Wenbing Zhang (ORCID: https://orcid.org/0000-0001-8553-6565)
- Zhihua Chen (ORCID: https://orcid.org/0000-0003-2457-4802)
- Ye Lu (ORCID: https://orcid.org/0009-0007-5957-5596)
- Mengyu Zhao (ORCID: https://orcid.org/0009-0004-9997-7352)
- Jidong Gao
- Chenling Tang
Institutions
- Anhui Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Soochow University (CN)
- Zhongshan Hospital (CN)
- Anqing City Hospital (CN)
- Taizhou First People's Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.3389/fimmu.2025.1532306
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05